Our ENDO 2026 Plenary Lineup | We are excited to announce the ENDO Plenaries! Watch our president, Carol Lange, PhD, announce the distinguished plenary speakers and what they will be exploring at ENDO 2026: bit.ly/3MpRMlK #ENDO2026 #endocrinology #EndoSky

#ENDO2026 Abstract Submitters: The deadline for our Outstanding Abstract Awards is Thursday, January 15. Select the Outstanding Abstract Awards option during abstract submission to apply. Learn more: https://bit.ly/49lxDqp #endocrinology

The latest paper from our group is now out! Extracelluar vesicles from neutrophils drive breast cancer cells towards being more stem-like; important consequences for chemotherapy. News story and summary here: cancer.illinois.edu/researchers-... . Publication found here: doi.org/10.1016/j.ca... .

Join the CCIL Cancer Research Advocacy Group for an online seminar focused on supporting mental health during a cancer diagnosis. Strategies for coping and finding empowerment through the journey - from an oncology counselor and survivors' perspectives. forms.illinois.edu/sec/50084012...

Watch our videos with Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, on creation of ENDO programming and how submitting a session idea can help you in your career. She provides insight in English (bit.ly/3UOXNJB) and Español (bit.ly/47RuYUz). #ENDO2026 #endocrinology

What were your favorite articles in the current issue of @endocrinenews.bsky.social? Our cover story interviews Erik Nelson, PhD. Our features explore diabetes and liver disease and a Q&A C. Wayne Bardin International Travel Award Winner Yoshitomo Hoshino, MD, PhD. Read more: https://bit.ly/3UZMPkw

Help shape ENDO2026! Submit your suggestions for great endocrine society science now!

Thanks for an amazing #ENDO2025! We will see you next year! @endocrinesociety.bsky.social #endosky

@endocrinesociety.bsky.social #ENDO2025 rocking out to this beauty: youtu.be/KsBgcEvihS8?...

My amazing colleague @loriraetzman.bsky.social the 2025 Endoctrine Society Laureate Awardee for distinguished service. #ENDO2025 @endocrinesociety.bsky.social

Arrived at SFO #ENDO2025 @endocrinesociety.bsky.social

Some amazing programming about to happen at #ENDO2025 !! @endocrinesociety.bsky.social

#Illinois researchers have successfully treated a common type of colorectal cancer tumor with a cholesterol inhibitor drug, demonstrating a promising treatment for the disease in animal experiments. The study was published in Nature Chemical Biology: go.mcb.illinois.edu/623 @nelsonlab.bsky.social

I am very proud to have helped develop Elacestrant for the treatment of breast cancer. There is still much to be done - and we show up to lab every day striving to do better for patients. Stories like these inspire us: www.youtube.com/watch?v=Puk6... #endcancer #BCSM #breastcancer #stage4

New review paper from the lab highlighting cholesterol, the immune system and tumor biology. PhD co-authors discuss its importance in this interview.

Just a day away! Join the Cancer Research Advocacy Group for a special webinar on survivorship. Great tips on navigating the insurance system! Register here: forms.illinois.edu/sec/380306938

Why I Study Cancer The cancers that are fatal today don't have to be tomorrow. Support for biomedical research enables generational shifts in how we treat cancer. What a privilege to work at @cancercenteril. Work funded by National Institutes of Health www.instagram.com/reel/DGTUxwD...

A bit after-the-fact, but thanks to WAND -TV for highlighting our work! www.wandtv.com/news/u-of-i-...

Drug candidate eliminates breast cancer tumors in mice in a single dose "This effect is robust and independent of tumor size with eradication of even very large tumors." Open Access pubs.acs.org/doi/10.1021/...

Truly life-changing work is being done by Nelson and this team of researchers here in C-U to fight against cancer in new ways.